EuroGen Pharmaceuticals withdraws its application for Orathecin

The European Medicines Agency has been formally notified by EuroGen Pharmaceuticals Ltd of its decision to withdraw its application for marketing authorisation for the medicinal product Orathecin (rubitecan). ... Read more